Pharmacia
This article was originally published in The Tan Sheet
Executive Summary
Nicorette "still in its infancy in many significant countries" such as Germany, Italy, Spain, where sales not yet on par with smaller Ireland market, VP-Global Specialty Operations Stephen MacMillan tells investors Nov. 29. Sales are up 28% for first nine months of 2001, spurred by new global marketing campaign, reacquisition of brand from Canadian distributor and recent OTC switch in Japan, where sales are $1 mil. per week. MacMillan also heralded 8.5% sales increase for Pharmacia's global consumer healthcare - about triple the industry average - and 13% sales growth in North America...You may also be interested in...
Nicorette International Growth Integral To Pfizer OTC Strength – Hassan
Nicorette Global Sales Jump 62% In Q4 With International Expansion
Biogen’s Big Day Arrives, But Aducanumab Results Don’t Answer Key Question
Biogen presented highly anticipated data in Alzheimer’s disease at CTAD for its Phase III EMERGE and ENGAGE studies, but one major question remains unanswered: will the FDA approve the drug?
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: